Search
Contulakin-G
go.drugbank.com/drugs/DB05950ExperimentalIt is the synthetic form of a natural peptide extracted from the venom of the Conus Geographus sea snail.
Otamixaban
go.drugbank.com/drugs/DB06635InvestigationalIt is currently being developed by the French pharmaceutical company Sanofi-Aventis as a treatment for acute coronary syndrome.
Indole-3-carbinol
go.drugbank.com/drugs/DB12881InvestigationalIndole 3 Carbinol is under investigation in clinical trial NCT00033345 (Indole-3-Carbinol in Preventing Breast Cancer in Nonsmoking Women Who Are at High Risk For Breast Cancer).
ASP-8731
go.drugbank.com/drugs/DB17696InvestigationalDeveloped by Mitobridge, it is being investigated for the treatment of sickle cell disease.[L46093]
BEA-17
go.drugbank.com/drugs/DB18574Experimental[L48330] It is under investigation for the treatment of glioblastoma.
Florzolotau F-18
go.drugbank.com/drugs/DB16297InvestigationalPMPBB3 F-18 is under investigation in clinical trial NCT04305210 (Alzheimer's Disease: Clinical Investigation and Neuroimage Studies Including 18F-PM-PBB3 and 18f-florbetapir (AV-45) PET Examination).
Rocakinogene sifuplasmid
go.drugbank.com/drugs/DB16316InvestigationalRocakinogene sifuplasmid is under investigation in clinical trial NCT03491683 (INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination With Cemiplimab (REGN2810) in Newly-diagnosed Glioblastoma
Tandamine
go.drugbank.com/drugs/DB09192ExperimentalTandamine is an analog of pirandamine and it acts as a selective serotonin reuptake inhibitor (SSRI).
Arsanilic acid
go.drugbank.com/drugs/DB03006ExperimentalVet approvedIt causes blindness and is ototoxic and nephrotoxic in animals. [PubChem]